OB/GYN 1102 - OB/GYN Clinical Alert - Feb 01, 2007

Target Audience:

This activity is intended for the obstetrician and gynecologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Leon Speroff, MD
Professor of Obstetrics and Gynecology
Oregon Health and Science University

Peer Reviewer
Catherine Leclair, MD
Assistant Professor
Department of OB/GYN
Oregon Health and Science University

Associate Editors
John C. Hobbins, MD
Professor and Chief of Obstetrics
University of Colorado Health Sciences Center

Robert L. Coleman, MD
Associate Professor
University of Texas; M.D.
Anderson Cancer Center

Frank W. Ling, MD
Clinical Professor
Dept. of Obstetrics
University of Colorado Health Services


  • Decline in Breast Cancer and Reduced Use of Hormone Therapy
  • Breast Cancer Risk in Finnish Women Using Estrogen-Only Therapy
  • Pregnancy after Uterine artery embolization for uterine fibroids
  • Additional support OCP's reduce ovarian cancer risk
  • How Best to Medically Manage Ectopic Pregnancy?
  • Phenotypic Differences between Male Physicians, Surgeons, and Film Stars: Comparative Study


  • To present the latest data regarding diagnosis and treatment of various diseases affecting women, including cancer, sexually transmitted diseases, and osteoporosis
  • To present new data concerning prenatal care and complications, as well as neonatal health
  • To discuss the pros, cons, and cost-effectiveness of new testing procedures

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Leon Speroff, MD, is a consultant for Warner Chilcott and does research for Wyeth.

Peer Reviewer Catherine Leclair, MD, Associate Editors John C. Hobbins, MD, and Frank W. Ling, MD, reports no financial relationship to this field of study.

Associate Editor Robert L. Coleman, MD is on the speaker’s bureau for GlaxoSmithKline, Bristol-Myers Squibb, and Ortho Biotech.

Copyright 2007 AHC Media. All rights reserved.